Literature DB >> 28833973

Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis.

Cristina Mugheddu1, Laura Atzori1, Maria Del Piano2, Astrid Lappi1, Monica Pau1, Severino Murgia1, Ignazio Zucca3, Franco Rongioletti1.   

Abstract

We report the first successful treatment of noninfectious uveitis with ustekinumab in a patient with severe concomitant psoriasis and psoriatic arthritis who failed to respond to conventional immune suppressants and with contraindications to tumor necrosis factor alpha inhibitors.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  noninfectious uveitis; psoriasis; psoriatic arthritis; therapy; ustekinumab

Mesh：

Substances：

Year:  2017        PMID： 28833973     DOI： 10.1111/dth.12527

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


  14 in total

Review 1.  A Review of Systemic Biologics and Local Immunosuppressive Medications in Uveitis.

Authors:  Neesurg S Mehta; Parisa Emami-Naeini
Journal:  J Ophthalmic Vis Res       Date:  2022-04-29

Review 2.  Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis.

Authors:  Kathryn L Pepple; Phoebe Lin
Journal:  Ophthalmology       Date:  2018-07-04       Impact factor: 12.079

Review 3.  Psoriasis beyond the skin: Ophthalmological changes (Review).

Authors:  Maria-Magdalena Constantin; Maria-Diana Ciurduc; Stefana Bucur; Rodica Olteanu; Razvan Adrian Ionescu; Traian Constantin; Florentina Furtunescu
Journal:  Exp Ther Med       Date:  2021-07-12       Impact factor: 2.447

4.  Association between uveitis and psoriatic disease: a systematic review and Meta-analysis based on the evidence from cohort studies.

Authors:  Chao-Ran Li; Lang Chen; Long-Fei Wang; Bin Yan; You-Ling Liang; Jing Luo
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

Review 5.  Emerging treatment options for extraintestinal manifestations in IBD.

Authors:  Thomas Greuter; Florian Rieder; Torsten Kucharzik; Laurent Peyrin-Biroulet; Alain M Schoepfer; David T Rubin; Stephan R Vavricka
Journal:  Gut       Date:  2020-08-26       Impact factor: 31.793

6.  Tofacitinib for refractory uveitis and scleritis.

Authors:  Michael A Paley; Humeyra Karacal; P Kumar Rao; Todd P Margolis; Jonathan J Miner
Journal:  Am J Ophthalmol Case Rep       Date:  2018-12-04

Review 7.  Old and New Challenges in Uveitis Associated with Behçet's Disease.

Authors:  Julie Gueudry; Mathilde Leclercq; David Saadoun; Bahram Bodaghi
Journal:  J Clin Med       Date:  2021-05-26       Impact factor: 4.241

8.  The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies.

Authors:  Neeraj Narula; Achuthan Aruljothy; Emily C L Wong; Ravi Homenauth; Abdul-Aziz Alshahrani; John K Marshall; Walter Reinisch
Journal:  United European Gastroenterol J       Date:  2021-06-02       Impact factor: 4.623

Review 9.  Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system.

Authors:  Elsa How Shing Koy; Pierre Labauge; Athan Baillet; Clément Prati; Hubert Marotte; Yves-Marie Pers
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-09       Impact factor: 5.346

Review 10.  Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis.

Authors:  Lipeng Tang; Xiaozhi Yang; Yongxin Liang; Hesong Xie; Zhenhua Dai; Guangjuan Zheng
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.